Clinical Trial Update: Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma

View source ↗

Summary

This clinical trial is evaluating a non-invasive DNA methylation-based assay for risk assessment of bladder cancer (urothelial carcinoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Bladder Cancer | Status: UNKNOWN